Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Gritsch

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2023
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma-derived von Willebrand factor productsPeter L Turecek, Reinhard Ilk, Herbert Gritsch
Bio-Protocol|October 6, 2022
Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel ElectrophoresisHerbert Gritsch, Margit Stimpfl, Peter L Turecek
Research and Practice in Thrombosis and Haemostasis|October 18, 2022
Selective human factor VIII activity measurement after analytical in-line purificationAndrea Engelmaier, Gerald Schrenk, Manfred Billwein, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 25, 2018
Issues complicating precision dosing for factor VIII prophylaxisLeonard A Valentino, Peter L Turecek, Herbert Gritsch, et al.
Electrophoresis|April 27, 2011
Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGEChristina Monetti, Hanspeter Rottensteiner, Herbert Gritsch, et al.
Journal of Blood Medicine|November 21, 2022
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand DiseaseHerbert Gritsch, Gerald Schrenk, Nina Weinhappl, et al.
Thrombosis Research|April 1, 2014
High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13Thorsten Kragh, Marina Napoleone, Mohammad A Fallah, et al.
Bio-Protocol|September 16, 2024
An Automated pre-Dilution Setup for Von Willebrand Factor Activity AssaysTobias Schachinger, Ann-Katrin Holik, Gerald Schrenk, et al.
British Journal of Haematology|November 18, 2003
Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse modelSimone Schatz, Peter L Turecek, Christian Fiedler, et al.
Seminars in Thrombosis and Hemostasis|July 16, 2010
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitabilityEva-Maria Muchitsch, Barbara Dietrich, Hanspeter Rottensteiner, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 5, 2023
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma-derived von Willebrand factor productsPeter L Turecek, Reinhard Ilk, Herbert Gritsch
Bio-Protocol|October 6, 2022
Von Willebrand Factor Multimer Analysis by Low Resolution SDS-Agarose Gel ElectrophoresisHerbert Gritsch, Margit Stimpfl, Peter L Turecek
Research and Practice in Thrombosis and Haemostasis|October 18, 2022
Selective human factor VIII activity measurement after analytical in-line purificationAndrea Engelmaier, Gerald Schrenk, Manfred Billwein, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 25, 2018
Issues complicating precision dosing for factor VIII prophylaxisLeonard A Valentino, Peter L Turecek, Herbert Gritsch, et al.
Electrophoresis|April 27, 2011
Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGEChristina Monetti, Hanspeter Rottensteiner, Herbert Gritsch, et al.
Journal of Blood Medicine|November 21, 2022
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand DiseaseHerbert Gritsch, Gerald Schrenk, Nina Weinhappl, et al.
Thrombosis Research|April 1, 2014
High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13Thorsten Kragh, Marina Napoleone, Mohammad A Fallah, et al.
Bio-Protocol|September 16, 2024
An Automated pre-Dilution Setup for Von Willebrand Factor Activity AssaysTobias Schachinger, Ann-Katrin Holik, Gerald Schrenk, et al.
British Journal of Haematology|November 18, 2003
Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse modelSimone Schatz, Peter L Turecek, Christian Fiedler, et al.
Seminars in Thrombosis and Hemostasis|July 16, 2010
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitabilityEva-Maria Muchitsch, Barbara Dietrich, Hanspeter Rottensteiner, et al.
Pageof 2